Teckro has introduced its new Patient Data Return feature, providing patients with seamless access to their medical reports while giving sponsors greater oversight into engagement levels.
Ellie Gabel, Associate Editor for Revolutionized explains how cleaning and sterilisation are essential but often unoptimised processes within pharmaceutical facilities.
Infinitopes has announced that the UK Medicines and Healthcare products Regulatory Agency has granted Clinical Trial Application (CTA) approval for the first-in-human Phase I/IIa clinical trial of ITOP1, the company’s ‘off-the-shelf’ cancer vaccine.
Shilpa Medicare announces that Shilpa Pharma Lifesciences – a wholly owned subsidiary – has successfully passed a U.S. Food and Drug Administration (FDA) inspection for its Unit-2 facility in Raichur, India, with no 483 observations.
IFF Pharma Solutions has announced the launch of Low Nitrite METHOCEL hydroxypropyl methylcellulose (HPMC), a range of low nitrite cellulose ethers developed to reduce the risk of nitrosamine formation in finished pharmaceutical dosages.
Berry Global’s presence at this year’s Maghreb Pharma Expo highlights the company’s commitment to supporting growth in emerging healthcare markets across North Africa.
Reading Scientific Services (RSSL) has been awarded the title of ‘Best Performing Professional Services Company of the Year’ at the 2025 ON Awards, hosted by One Nucleus.
BDD has opened its 122m² GMP manufacturing facility at BioCity near Glasgow, following an inspection by the Medicines and Healthcare products Regulatory Authority (MHRA) in March 2025.
After Artiva Biotherapeutics announced the news of cryopreserved allogeneic NK cell therapies (AlloNK) for treating autoimmune disease, European Pharmaceutical Manufacturer spoke to Fred Aslan, president and CEO to learn more.
Beckman Coulter Life Sciences introduces the Next-Generation Basophil Activation Test (BAT) for research use only to more effectively characterise allergies without exposure to potentially harmful allergens.
